Trial
NCT01350232
Treatment of Sickle Cell Anemia With Stem Cell Transplant
UnknownTERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Collaborators
National Heart, Lung, and Blood Institute (NHLBI)
Condition
Sickle Cell Anemia
Intervention
Fludarabine
Why stopped
Poor accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-05-16